XML 49 R37.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Merger (Details) - Schedule of Common Stock and Series A Preferred Stock Outstanding
6 Months Ended
Jun. 30, 2024
shares
Class A Common Stock [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Subtotal - Merger, net of redemptions 4,115,874
Total common stock outstanding 19,549,982
Class A Common Stock [Member] | Exchange of Anzu Class A Common Stock subject to possible redemption that was not redeemed for Common Stock [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Subtotal - Merger, net of redemptions 1,500,874
Class A Common Stock [Member] | Conversion of Anzu Class B Common Stock held by the Sponsor and Anzu’s former independent director into Common Stock [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Subtotal - Merger, net of redemptions 2,615,000 [1]
Class A Common Stock [Member] | Exchange of Envoy Common Stock for Common Stock [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total common stock outstanding 8,850,526
Class A Common Stock [Member] | Exchange of Envoy Preferred Stock for Common Stock [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total common stock outstanding 1,272,055
Class A Common Stock [Member] | Conversion of Convertible Notes as of September 29, 2023 into Common Stock [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total common stock outstanding 4,874,707
Class A Common Stock [Member] | Net exercise of Envoy Warrants [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total common stock outstanding 2,702
Class A Common Stock [Member] | Issuance of share consideration to Meteora parties [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total common stock outstanding 8,512
Class A Common Stock [Member] | Shares recycled by Meteora parties [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total common stock outstanding 425,606
Series A Preferred Stock [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total preferred stock outstanding 4,500,000
Series A Preferred Stock [Member] | Exchange of Anzu Class B Common Stock for Series A Preferred Stock [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total preferred stock outstanding 2,500,000
Series A Preferred Stock [Member] | Issuance of Series A Preferred Stock in connection with the PIPE Transaction [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total preferred stock outstanding 1,000,000
Series A Preferred Stock [Member] | Issuance of Series A Preferred Stock in connection with the conversion of the Envoy Bridge Note [Member]  
Common Stock and Series A Preferred Stock Outstanding [Line Items]  
Total preferred stock outstanding 1,000,000
[1] 1,000,000 shares of the Common Stock are unvested and subject to restrictions and forfeitures per the Sponsor Support Agreement. These shares will vest upon the FDA approval of Acclaim CI or upon a change of control of the Company (see Note 10)